Biora Therapeutics, Inc.
BIORQ
$0.1174
-$0.0086-6.83%
| Weiss Ratings | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.81 | |||
| Price History | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.56% | |||
| 30-Day Total Return | -34.08% | |||
| 60-Day Total Return | -91.43% | |||
| 90-Day Total Return | -96.65% | |||
| Year to Date Total Return | -41.42% | |||
| 1-Year Total Return | -98.99% | |||
| 2-Year Total Return | -99.61% | |||
| 3-Year Total Return | -99.96% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -99.05% | |||
| 52-Week Low % Change | 57.50% | |||
| Price | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $13.30 | |||
| 52-Week Low Price | $0.08 | |||
| 52-Week Low Price (Date) | Feb 25, 2025 | |||
| 52-Week High Price (Date) | Mar 26, 2024 | |||
| Valuation | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 557.31K | |||
| Enterprise Value | 37.76M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -13.03 | |||
| Earnings Per Share Growth | -86.41% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.52 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | 42.33 | |||
| Price | $0.12 | |||
| Enterprise Value/EBITDA (TTM) | -0.62 | |||
| Enterprise Value/EBIT | -0.62 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 3.65M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 833 727 2841 | |||
| Address | 4330 La Jolla Village Drive San Diego, CA 92122 | |||
| Website | www.bioratherapeutics.com | |||
| Country | United States | |||
| Year Founded | 2010 | |||
| Profitability | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -6,824.32% | |||
| Profit Margin | -3,535.76% | |||
| Management Effectiveness | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -154.63% | |||
| Return on Equity | -- | |||
| Income Statement | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 892.00K | |||
| Total Revenue (TTM) | 892.00K | |||
| Revenue Per Share | $0.24 | |||
| Gross Profit (TTM) | 892.00K | |||
| EBITDA (TTM) | -60.42M | |||
| EBIT (TTM) | -60.87M | |||
| Net Income (TTM) | -31.54M | |||
| Net Income Avl. to Common (TTM) | -31.54M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 69.75% | |||
| EPS Diluted (TTM) | -13.03 | |||
| EPS Diluted Growth (Q YOY) | 89.70% | |||
| Balance Sheet | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.20M | |||
| Cash Per Share (Q) | $0.87 | |||
| Total Current Assets (Q) | 6.05M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -106.63M | |||
| Current Ratio (Q) | 0.050 | |||
| Book Value Per Share (Q) | -$28.99 | |||
| Total Assets (Q) | 14.51M | |||
| Total Current Liabilities (Q) | 120.62M | |||
| Total Debt (Q) | 40.40M | |||
| Total Liabilities (Q) | 121.13M | |||
| Total Common Equity (Q) | -106.63M | |||
| Cash Flow | BIORQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 2.81M | |||
| Cash from Financing (TTM) | 17.36M | |||
| Net Change in Cash (TTM) | -12.02M | |||
| Levered Free Cash Flow (TTM) | -3.55M | |||
| Cash from Operations (TTM) | -32.18M | |||
